POMDOCTOR Ltd (POM)
POMDOCTOR Ltd at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
POMDOCTOR Ltd (POM) is a Medical - Pharmaceuticals company based in CN with a market capitalization of $12.7M. Revenue grew 12.4% year-over-year and free cash flow was negative at -$2.4M. This page tracks POM's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
CN · 156 employees · IPO Oct 8, 2025
Valuation
Valuation & price
$0.11 · as of May 17, 2026 · -99.9% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
—
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$12.7M
Market cap
12.4%
Revenue growth (YoY)
13.9%
Gross margin
-$2.4M
Free cash flow (USD)
$433.5M
Net debt
0.0%
Share dilution
0/3
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2021 → 2024
Free cash flow by year
2021 → 2024
Gross margin by year
2021 → 2024
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last report: 6-K filed May 14, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- 6-K filingStrategic UpgradeJul 2, 2026Filing
- 6-K filingADS Ratio ChangeJun 17, 2026Filing
- 6-K filingADS Ratio ChangeMay 28, 2026Filing
- Annual reportAnnual Report FiledMay 14, 2026Filing
- Annual report20-F FiledMay 14, 2026Filing
- Annual reportAnnual Report FiledApr 20, 2026Filing
- 6-K filingManagement ChangeApr 8, 2026Filing
Questions
Frequently asked questions
What is POMDOCTOR Ltd's market cap?
POMDOCTOR Ltd (POM) has a market capitalization of $12.7M.
What is POM's P/E ratio?
A meaningful P/E ratio is not available for POM — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
Are insiders buying POM stock?
SEC Form 4 filings show no open-market insider buys at POMDOCTOR Ltd in the last 90 days (0 sells).
Same arena
Related companies in Medical - Pharmaceuticals
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.